Q3 2025 IPCA Laboratories Ltd Earnings Call Transcript

Feb 13, 2025 / 10:00 AM GMT

Release Date Price: ₹1490.9 (+5.01%)

Transcript

Key Points

Positve

Ipca Laboratories Ltd (BOM:524494) reported a 13% growth in its domestic formulation business for the quarter.
The company's market share improved by 11 basis points, reaching 2.05% in the current financial year.
EBITDA margins improved significantly, with standalone margins at 24.25% compared to 18.52% in the previous year.
The company's chronic segment showed strong growth, with a 17.1% increase, outperforming the market.
The API business also delivered a robust growth of around 12% for the quarter.

Negative

The US business has not yet shown significant impact on overall consolidated numbers due to the nascent stage of market penetration.
The generic business faced challenges, particularly in South Africa, due to lost tender orders, impacting overall numbers.
Institutional business faces uncertainty due to potential funding issues from US aid programs.
The company is still assessing the impact of halted US aid on its anti-malarial business, which could affect future revenues.
There are ongoing challenges in the API export market, with some key markets like Iran showing zero business due to currency issues.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

IPCA.NS - IPCA Laboratories Ltd
Q3 2025 IPCA Laboratories Ltd Earnings Call
Feb 13, 2025 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to IA Labor TQ 3 FY25 earning conference call Jose by them Capital Advisors Limited. As a reminder, all participants will be in the listing only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an update by pressing, then 0 on attached on phone.

Please note that this conference is being recorded. I now hand the conference over to Mr. Nitin Agarwal from Dem Capital Advisors.

Thank you and over to you, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.